CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • CDMO
  • Top Contract Development and Manufacturing Organizations (CDMOs)

Top Contract Development and Manufacturing Organizations (CDMOs)

This listing highlights CDMOs helping pharmaceutical companies, biotech innovators, therapy developers and life sciences partners improve formulation development, manufacturing scale-up, regulatory readiness and product commercialization with outsourced development and manufacturing capabilities. Selections reflect operational reliability, technical value, execution depth and market confidence, reinforced by subscriber nominations, editorial review, expert evaluation and industry perspective.
Top Contract Development and Manufacturing Organizations (CDMOs)

Nominate a Company

Usually, the qualified subscribers of our magazine nominate companies with whom they have collaborated and experienced exceptional results to be in this list. Did a company you recently worked with give you stellar results and ROI? Did it turn out to be one you would wholeheartedly recommend to peers? Or do you know of such an outstanding company through your network? Please fill in the details below and nominate them to be featured here.

* 

captcha
Can't read the image? click here to refresh

Thank You!

checkmark

We are glad to receive your nomination. Our editorial team and evaluation panel will review your submission. Thank you for taking the time to highlight an organization driving impactful change in Lifescience Review.

Data not inserted

    Top Contract Development and Manufacturing Organizations (CDMOs)

    ★Featured Companies
    Abzena
    Abzena
    Read full profile →
    Abzena is a leading integrated complex biologics & bioconjugate CDMO + CRO specializing in Antibody-drug conjugates (ADCs), antibody-oligonucleotide conjugates (AOCs) and bi/multi-specifics. Combining deep scientific expertise with a ... read full profile
    Catalent
    Catalent
    Catalent is a leading global contract development and manufacturing organization (CDMO) that partners with pharmaceutical, biotech, and consumer health companies to develop, deliver, and supply superior products that improve people's lives.
    Hovione
    Hovione
    Hovione is a Contract Development and Manufacturing Organization (CDMO) specializing in bringing new and off-patent drugs to market. They offer services in drug substance development, particle engineering, and drug product manufacturing. Hovione operates FDA-inspected facilities in the U.S., Portugal, Ireland, and China.
    Kindeva Drug Delivery
    Kindeva Drug Delivery
    Kindeva Drug Delivery is a global contract development and manufacturing organization (CDMO) specializing in drug-device combination products. They offer comprehensive services, including aseptic fill-finish, manufacturing, and analytical support, across various delivery routes such as pulmonary, nasal, injectable, and dermal applications.
    Patheon [PTHN.NYSE]
    Patheon [PTHN.NYSE]
    Patheon, a Thermo Fisher Scientific brand, offers comprehensive contract development and manufacturing services for pharmaceuticals, including drug development, clinical trial logistics, and commercial manufacturing.
    Piramal Pharma Solutions [NSE: PPLPHARMA]
    Piramal Pharma Solutions [NSE: PPLPHARMA]
    Piramal Pharma Solutions is a global contract development and manufacturing organization (CDMO) offering integrated services across the drug lifecycle, including drug discovery, development, and commercial manufacturing.

CDMO News

Smart Chromatography: Transforming Analysis with Advanced Technologies

Thursday, August 06, 2026

Fremont, CA: Chromatography is a method that has long been trusted for separating and identifying the different components of complex chemical and biological mixtures. As the need for more accurate testing has increased, traditional separation methods have proven insufficient for many applications. Laboratories are now dealing with increasingly complicated samples, which require a high level of precision. This growing complexity is driving improvements in chromatography. Modern chromatography systems do more than just accurately separate components; they are designed to enhance laboratory efficiency, yield results quickly, detect trace amounts of substances and

Bioconjugates CDMO Services: Navigating Today's Innovations and Tomorrow's Possibilities

Wednesday, March 05, 2025

Bioconjugate contract development and manufacturing organization (CDMO) services are vital to the pharmaceutical and biotechnology sectors. These services facilitate the development and production of intricate bioconjugates, including antibody-drug conjugates (ADCs), critical for targeted therapeutic approaches. By offering specialized knowledge in process development, formulation, and large-scale manufacturing, CDMOs assist in expediting the transition from research to market. This support allows pharmaceutical companies to concentrate on innovation and patient care, ultimately providing advanced and effective treatment options. Market Shifts and Hurdles

CDMO Info

Q1
What Do Top Contract Development and Manufacturing Organizations (CDMOs) Do?
Top Contract Development and Manufacturing Organizations (CDMOs) help pharmaceutical, biotech and life sciences companies develop and manufacture drug products without building every capability in-house. Their work can include formulation development, analytical testing, process scale-up, clinical supply production and commercial manufacturing. Some support early-stage research programs, while others help companies move therapies through clinical development and into large-scale production. In practice, CDMOs often become long-term technical partners. The strongest ones do more than manufacture products. They help sponsors solve production challenges, improve process stability and prepare for regulatory review as programs grow.
Q2
Why Do Top Contract Development and Manufacturing Organizations (CDMOs) Matter Now?
Top Contract Development and Manufacturing Organizations (CDMOs) matter because drug development has become more complex, expensive and specialized. Many biotech companies do not have their own manufacturing facilities, while larger pharmaceutical companies often need additional capacity or technical expertise for certain products. Demand has also increased around biologics, sterile manufacturing and advanced therapies that require highly controlled production environments. Sponsors are under pressure to move faster without compromising quality, documentation or regulatory readiness. A strong CDMO can help reduce delays between development stages and make manufacturing plans more stable as products advance.
Q3
How Should Life Sciences Companies Evaluate CDMO Providers?
The first step is understanding whether the CDMO actually fits the product and development stage. A company working on sterile injectables, for example, needs very different expertise and facility controls than one developing oral solid dose products. Decision-makers should review manufacturing capabilities, inspection history, quality systems, analytical expertise and experience with similar molecules or dosage forms. It is also important to look beyond presentations and ask how the organization handles tech transfer, deviations, batch release issues and project communication. Problems in these areas often create delays once timelines become more demanding.
Q4
What Business Value Do Contract Development and Manufacturing Services Create?
Strong CDMOs help companies avoid the cost and complexity of building large manufacturing operations internally. That support can shorten development timelines, improve scale-up planning and give sponsors access to specialized expertise that would otherwise take years to develop. The value often appears through fewer manufacturing delays, cleaner documentation and more predictable product supply. For many sponsors, outsourcing manufacturing also allows internal teams to focus more on research, clinical strategy and commercialization rather than day-to-day production management.
Q5
How Do Technology and Expertise Shape CDMO Performance?
Technology matters when it improves consistency, traceability and process control. Many CDMOs now use digital batch records, automation, advanced analytics and integrated laboratory systems to reduce manual errors and improve documentation quality. Even so, technology alone does not guarantee strong performance. Experienced scientists, engineers and quality teams still play the biggest role in identifying scale-up risks, solving process issues and managing regulatory expectations. The best CDMOs combine modern systems with practical manufacturing knowledge and disciplined execution.
Q6
What Should Drug Sponsors Prioritize When Comparing CDMO Options?
Sponsors should focus on technical fit, communication quality and operational reliability. The best CDMO is not always the largest or most visible provider. It is usually the organization with the right manufacturing platform, realistic capacity, responsive project management and a strong quality culture that matches the product’s needs. Buyers should also examine how the CDMO handles deviations, timeline risks, technology transfer and ongoing communication. Once a program reaches validation, regulatory filing or commercial supply, changing manufacturing partners becomes far more difficult and expensive.
Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://cdmo.lifesciencesreview.com/vendors/top-contract-development-and-manufacturing-organizations.html